We Should Reconsider Curing Diseases

The potential to deliver one shot cures is oe of the most attractive aspects of gen therapy, genetically engineered cell therapy, gen editing. Such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies. While the proposition carries tremendous value for patients and society, it could represent a challenge for geno medicine developers looking for sustained cash flow. If violence is the disease, an the military industrial complexes the treatment,. It's not a cure, it's a treatment. And tesly have to pay for the treatment. The truth is that cancer comes from so many different sources that there's not like a single cure for cancer. So if we stop making medicine, we won't be